Especificaciones tcnicas DCI Body protection compound 157 Clase Pentadecapptido sinttico (15 aminocidos) derivado de una protena gstrica Dianas Sin diana confirmada Peso molecular No disponible Frmula molecular No disponible Longitud de secuencia 15 aa Nmero CAS No disponible Semivida No disponible Presentacin Vial liofilizado, tapn de bromobutilo, sello de aluminio Actualizado 2026-07-30 Pureza HPLC y COA Especificacin de pureza: 98.0 % (HPLC)
A detailed review of BPC-157 and the nitric-oxide system documents this angiogenic mechanism in depth
7 Underlying mechanisms include obesity-related comorbidities (T2DM, cardiovascular and renal diseases), immune system impairments facilitating a systemic diffusion of infection, increased type 2 inflammation with effects on the lung parenchyma, raised IL-6 levels, and abnormal secretion of adipokines and cytokines inducing low-grade inflammation
Step 4: Establish schedule Choose specific times for administration
Patients are typically responsible for any deductibles, copays, or additional services not covered by insurance